Fleck Mark W, Cornell Elizabeth, Mah Stephanie J
Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA.
J Neurosci. 2003 Feb 15;23(4):1219-27. doi: 10.1523/JNEUROSCI.23-04-01219.2003.
The glutamate receptor (GluR) agonist-binding site consists of amino acid residues in the extracellular S1 and S2 segments in the N-terminal and M3-M4 loop regions, respectively. Molecular and atomic level structural analyses have identified specific S1 and S2 residues that interact directly with ligands, interact with one another in a dimeric configuration, and influence channel gating and desensitization properties of AMPA receptors. Other studies suggest that KA receptor gating and desensitization may differ mechanistically. In particular, a leucine (L) to tyrosine (Y) mutation in the S1 segment of AMPA receptors is sufficient to block desensitization, whereas KA receptors naturally contain a tyrosine residue at the equivalent position (Y751 in GluR6) but retain the fast-desensitizing phenotype. We hypothesized that KA receptor desensitization is preserved by a compensatory substitution in the S2 segment. We generated a series of GluR6 mutants that converted individual S2 domain residues to their AMPA receptor equivalents. Various S2 mutations had effects on the kinetics of desensitization and recovery from desensitization, but no single amino acid substitution was found to block desensitization, as in the L/Y mutant AMPA receptors, or to prevent desensitization to KA. Other mutations designed to neutralize residues thought to interact across the dimer interface had dramatic effects on channel gating and desensitization. These results are consistent with a close but imperfect structural homology between AMPA and KA receptors and support the role of conserved S1S2 domain interactions at the dimer interface in GluR channel function.
谷氨酸受体(GluR)的激动剂结合位点分别由N端细胞外S1和S2片段以及M3 - M4环区域中的氨基酸残基组成。分子和原子水平的结构分析已经确定了与配体直接相互作用、以二聚体形式相互作用并影响AMPA受体通道门控和脱敏特性的特定S1和S2残基。其他研究表明KA受体的门控和脱敏在机制上可能有所不同。特别是,AMPA受体S1片段中的亮氨酸(L)到酪氨酸(Y)突变足以阻断脱敏,而KA受体在等效位置天然含有酪氨酸残基(GluR6中的Y751),但仍保持快速脱敏表型。我们假设KA受体的脱敏是通过S2片段中的补偿性替代得以保留。我们生成了一系列GluR6突变体,将单个S2结构域残基转换为它们的AMPA受体等效物。各种S2突变对脱敏动力学和脱敏恢复有影响,但没有发现单个氨基酸替代能像L/Y突变的AMPA受体那样阻断脱敏或防止对KA的脱敏。设计用于中和被认为在二聚体界面相互作用的残基的其他突变对通道门控和脱敏有显著影响。这些结果与AMPA和KA受体之间紧密但不完美的结构同源性一致,并支持二聚体界面处保守的S1S2结构域相互作用在GluR通道功能中的作用。